Deutsche Bank
RVMD icon

Deutsche Bank’s Revolution Medicines RVMD Stock Holding History

Deutsche Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166M Buy
888,019
+422,261
+91% +$61.7M 0.05% 346
2026
Q1 		$45.3M Buy
465,758
+433,541
+1,346% +$43.8M 0.02% 648
2025
Q4 		$2.57M Buy
32,217
+130
+0.4% +$8.52K ﹤0.01% 1664
2025
Q3 		$1.5M Buy
32,087
+1,968
+7% +$77.1K ﹤0.01% 1941
2025
Q2 		$1.11M Sell
30,119
-123,227
-80% -$4.73M ﹤0.01% 2034
2025
Q1 		$5.42M Sell
153,346
-24,037
-14% -$976K ﹤0.01% 1218
2024
Q4 		$7.76M Buy
177,383
+64,997
+58% +$3.28M ﹤0.01% 1124
2024
Q3 		$5.1M Buy
112,386
+20,853
+23% +$908K ﹤0.01% 1274
2024
Q2 		$3.55M Sell
91,533
-5,328
-6% -$199K ﹤0.01% 1371
2024
Q1 		$3.12M Sell
96,861
-20,974
-18% -$622K ﹤0.01% 1458
2023
Q4 		$3.38M Buy
117,835
+64,834
+122% +$1.56M ﹤0.01% 1421
2023
Q3 		$1.47M Buy
53,001
+6,378
+14% +$189K ﹤0.01% 1506
2023
Q2 		$1.25M Sell
46,623
-59,654
-56% -$1.46M ﹤0.01% 1865
2023
Q1 		$2.3M Buy
106,277
+19,729
+23% +$486K ﹤0.01% 1607
2022
Q4 		$2.06M Buy
86,548
+4,076
+5% +$86.7K ﹤0.01% 1637
2022
Q3 		$1.63M Sell
82,472
-1,193
-1% -$26.2K ﹤0.01% 1713
2022
Q2 		$1.63M Sell
83,665
-2,843
-3% -$55.3K ﹤0.01% 1880
2022
Q1 		$2.21M Sell
86,508
-3,755
-4% -$81.7K ﹤0.01% 1824
2021
Q4 		$2.27M Buy
90,263
+907
+1% +$25.6K ﹤0.01% 1913
2021
Q3 		$2.46M Sell
89,356
-19,629
-18% -$571K ﹤0.01% 1939
2021
Q2 		$3.46M Buy
108,985
+29,273
+37% +$1.02M ﹤0.01% 1774
2021
Q1 		$3.66M Buy
79,712
+46,045
+137% +$2.06M ﹤0.01% 1745
2020
Q4 		$1.33M Buy
33,667
+12,666
+60% +$501K ﹤0.01% 2239
2020
Q3 		$731K Buy
21,001
+13,565
+182% +$376K ﹤0.01% 2401
2020
Q2 		$235K Buy
7,436
+2,531
+52% +$79.6K ﹤0.01% 3057
2020
Q1 		$107K Buy
+4,905
New +$136K ﹤0.01% 3218

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Deutsche Bank's RVMD Position: Q2 2026 in Review

Deutsche Bank increased its Revolution Medicines (RVMD) stake by 91% in Q2 2026, buying an estimated $61.7M and bringing the position to 888,019 shares worth $166M. The position accounts for 0.05% of the portfolio, ranked #346.

Deutsche Bank first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Deutsche Bank held 888,019 shares of Revolution Medicines worth $166M as of Q2 2026.
  • Deutsche Bank bought 422,261 Revolution Medicines shares in Q2 2026, an estimated $61.7M.
  • Revolution Medicines made up 0.05% of Deutsche Bank's portfolio in Q2 2026, its #346 holding.
  • Deutsche Bank first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.